ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,740.32
      0.78%
      US Tech 100
      19,520.80
      1.23%
      Dow Jones
      41,988.84
      0.08%
      Brent Oil
      77.075
      -4.77%
      Bitcoin
      62,654.15
      0.70%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Talis Biomedical Corporation (TLIS)

      7. Talis Biomedical Corporation (TLIS) Financials

      Talis Biomedical Corporation

      Talis Biomedical Corporation (TLIS)

      Talis Biomedical Corporation (PK)
      4.38
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Talis Biomedical Corporation Financial Summary

      The current TLIS market cap is 7.98M. The company's latest EPS is USD -34.0171 and P/E is -0.13.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 581k140k195k73k0
      Operating Income -16.39M-16.97M-11.69M-10.22M-13.48M
      Net Income -15.03M-15.68M-13.46M-13.04M-8.85M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 3.98M10.94M8.19M4.81M2.13M
      Operating Income -26.7M-91.18M-191.82M-111.55M-64.05M
      Net Income -27.47M-91.13M-192.04M-113.01M-62.01M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 123.08M107.23M94.67M82.49M72.7M
      Total Liabilities 26.91M25.67M25.56M25.81M24.07M
      Total Equity 96.17M81.56M69.12M56.68M48.63M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 25.73M198.41M265.83M169.29M94.67M
      Total Liabilities 4.12M16.03M31.85M42.55M25.56M
      Total Equity -21.14M-108.57M233.98M126.74M69.12M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -30.74M-41.88M-53.24M-6.43M-17.76M
      Investing -509k-579k-486k30k114k
      Financing 33k33k33k2k2k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -24.33M-87.02M-171.38M-100.14M-53.24M
      Investing -578k-8.2M-2.87M-1.62M-486k
      Financing 39.61M246.75M234.43M406k33k

      Stats and Ratios

      Market Cap 7.98M
      Price to Earnings Ratio -0.13
      Price to Sales Ratio 3.74
      Price to Cash Ratio 0.1
      Price to Book Ratio 0.12
      Dividend Yield -

      Share Statistics

      Shares Outstanding 1.82M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.44 (9.8%)

      Company Info

      Company Name Talis Biomedical Corporation
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://talisbio.com
      Industry lab analytical instruments (3826)